Kemper investor day outlines path to 2024 target returns, $150M+ cost savings by 2025

KEMPER Corp

Aims for positive adjusted net operating profit in 1H'23 and underwriting profit in 2H'23; targets 10-12% ROE and 14-16% ROATCE by 2024.
Cost optimization: $150M+ annualized run-rate savings by end 2025; $36M in charges incurred to date on $61M realized savings.
Specialty P&C filed 43 points of rate since 2Q'21; expects >13% additional rate to earn-in through 2023; YE 2023 underlying combined ratio target 97-100%.
Investor day reaffirms focus on specialty auto and life; completed sale of Kemper Health (Reserve National) on 12/1/22.
Macro tailwinds cited: rising interest rates, declining mortality, moderating severity inflation improving profit outlook.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.